Takeda Pharmaceutical
298 hedge funds and large institutions have $1.02B invested in Takeda Pharmaceutical in 2024 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 118 increasing their positions, 84 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 4.56% → 4.79% (+0.23%)
11% less capital invested
Capital invested by funds: $1.15B → $1.02B (-$129M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
298
Holding in Top 10
–
Calls
$28.2M
Puts
$2.37M
Top Buyers
| 1 | +$45.2M | |
| 2 | +$12M | |
| 3 | +$8.48M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$7.11M |
| 5 |
BlackRock
New York
|
+$6.46M |
Top Sellers
| 1 | -$204M | |
| 2 | -$37M | |
| 3 | -$14.9M | |
| 4 |
Millennium Management
New York
|
-$13.4M |
| 5 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$8.33M |